NEW YORK (GenomeWeb News) – Roche today reported that sales for its diagnostics division grew 4 percent year over year at constant exchange rates for the first nine months of 2012, with molecular diagnostics showing single-digit growth and the applied science unit continuing to struggle.

For the nine months ended Sept. 30, Roche reported total diagnostics sales of CHF 7.50 billion ($8.09 billion) compared to CHF 7.10 billion for the first nine months of 2011. In Swiss francs its diagnostics sales were up 6 percent year over year.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

In an against-all-odds twist, a researcher studying exceeding rare FOXG1 mutations discovers her daughter has the syndrome.

An effort by Genomics Medicine Ireland is creating a database of diseases based on the genomics of people in Ireland. It now is looking into the possibility of including Scotland in its work.

In recent weeks, the direct-to-consumer genetics firm has rolled out a health hub where customers can share information concerning 18 common health conditions.

In PLOS this week, new genes associated with prostate cancer risk, genetic patterns in M. bovis, and more.